Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1300070
European Journal of Endocrinology, Vol 130, Issue 1, 70-79
Copyright © 1994 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaag, A. A
Right arrow Articles by Beck-Nielsen, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Vaag, A. A
Right arrow Articles by Beck-Nielsen, H.

Glucose–fatty acid cycle operates in humans at the levels of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations

Allan A Vaag, Aase Handberg, Peter Skøtt, Erik A Richter and Henning Beck-Nielsen

Vaag, AA, Handberg A, Skøtt P, Richter EA, Beck-Nielsen H. Glucose-fatty acid cycle operates in humans at the levels of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations. Eur J Endocrinol 1994;130:70–9. ISSN 0804–4643

Plasma non-esterified fatty acid concentrations were elevated acutely (Intralipid + heparin infusion) in 14 normal humans in order to study the effects of fatty acids on whole-body basal and insulin-stimulated glucose metabolism, and on activities of skeletal muscle key enzymes. Whole-body glucose metabolism was assessed using [3-3H]glucose and indirect calorimetry. Biopsies were taken from the vastus lateralis muscle during basal and insulin-stimulated (3 h, 40 mU·m–2·min1) steady-state periods. Total peripheral glucose uptake was unaffected by Intralipid infusion in the basal state, whereas it decreased during Intralipid infusion in the hyperinsulinemic state (10.7±0.7 vs 8.7±0.8 mg · kg–1 fat-free mass · min–1, p < 0.02). Intralipid infusion decreased whole-body glucose oxidation in the basal state (1.3±0.2 vs 0.8±0.1 mg·kg–1 fat-free mass·min–1, p<0.001) and during hyperinsulinemia (3.6±0.2 vs 1.7±0.2 mg·kg–1 fat-free mass·min–1 p<0.001). Whole-body non-oxidative glucose uptake increased during Intralipid infusion in the basal state and was unaffected in the hyperinsulinemic state. The skeletal muscle pyruvate dehydrogenase activity ratio decreased in the basal state during Intralipid infusion (55±6 vs 43±5%, p<0.05), whereas no statistical significant decrease in the pyruvate dehydrogenase activity ratio was observed during insulin infusion (57±8 vs 47 ± 5%, NS). Insulin increased the activity of the active form of pyruvate dehydrogenase on the control day, but not during Intralipid infusion. Activities of phosphofructokinase and glycogen synthase were unaffected by Intralipid infusion. Plasma glucose concentrations were similar during Intralipid infusion and on the control day, whereas Intralipid infusion increased the muscle glucose content in the basal state (1.36±0.09 vs 1.77±0.12 mmol/kg dry wt, p<0.05) and in the hyperinsulinemic state (1.23 ± 0.09 vs 1.82 ± 0.16 mmol/kg dry wt, p <0.05). Insulin increased the muscle lactate content on the control day (6.50±0.95 vs 8.65±0.77 mmol/kg dry wt, p<0.05), but not during Intralipid infusion. In conclusion, the glucose–fatty acid cycle operates in humans in vivo at the levels of both whole body and skeletal muscle during both low and high physiological insulin concentrations.

Allan Vaag, Department of Internal Medicine M, Odense University Hospital, Sdr. Boulevard, DK-5000, Odense C, Denmark




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. R. Kashyap, R. Belfort, R. Berria, S. Suraamornkul, T. Pratipranawatr, J. Finlayson, A. Barrentine, M. Bajaj, L. Mandarino, R. DeFronzo, et al.
Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes
Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E537 - E546.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Storgaard, C. B. Jensen, M. Bjornholm, X. M. Song, S. Madsbad, J. R. Zierath, and A. A. Vaag
Dissociation between Fat-Induced in Vivo Insulin Resistance and Proximal Insulin Signaling in Skeletal Muscle in Men at Risk for Type 2 Diabetes
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1301 - 1311.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. B. Jensen, H. Storgaard, J. J. Holst, F. Dela, S. Madsbad, and A. A. Vaag
Insulin Secretion and Cellular Glucose Metabolism after Prolonged Low-Grade Intralipid Infusion in Young Men
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2775 - 2783.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Staehr, O. Hother-Nielsen, B. R. Landau, V. Chandramouli, J. J. Holst, and H. Beck-Nielsen
Effects of Free Fatty Acids Per Se on Glucose Production, Gluconeogenesis, and Glycogenolysis
Diabetes, February 1, 2003; 52(2): 260 - 267.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Shah, A. Vella, A. Basu, R. Basu, A. Adkins, W. F. Schwenk, C. M. Johnson, K. S. Nair, M. D. Jensen, and R. A. Rizza
Elevated Free Fatty Acids Impair Glucose Metabolism in Women: Decreased Stimulation of Muscle Glucose Uptake and Suppression of Splanchnic Glucose Production During Combined Hyperinsulinemia and Hyperglycemia
Diabetes, January 1, 2003; 52(1): 38 - 42.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. S. Choi, Y.-B. Kim, F. N. Lee, J. M. Zabolotny, B. B. Kahn, and J. H. Youn
Lactate induces insulin resistance in skeletal muscle by suppressing glycolysis and impairing insulin signaling
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E233 - E240.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Nielsen, N. Moller, S. B. Pedersen, J. S. Christiansen, and J. O. L. Jorgensen
The Effect of Long-Term Pharmacological Antilipolysis on Substrate Metabolism in Growth Hormone (GH)-Substituted GH-Deficient Adults
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3274 - 3278.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. J Roef, K. de Meer, D.-J. Reijngoud, H. W. Straver, M. de Barse, S. C Kalhan, and R. Berger
Triacylglycerol infusion does not improve hyperlactemia in resting patients with mitochondrial myopathy due to complex I deficiency
Am. J. Clinical Nutrition, February 1, 2002; 75(2): 228 - 236.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Shah, A. Vella, A. Basu, R. Basu, A. Adkins, W. F. Schwenk, C. M. Johnson, K. S. Nair, M. D. Jensen, and R. A. Rizza
Effects of Free Fatty Acids and Glycerol on Splanchnic Glucose Metabolism and Insulin Extraction in Nondiabetic Humans
Diabetes, February 1, 2002; 51(2): 301 - 310.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Krebs, M. Krssak, P. Nowotny, D. Weghuber, S. Gruber, V. Mlynarik, M. Bischof, H. Stingl, C. Fürnsinn, W. Waldhäusl, et al.
Free Fatty Acids Inhibit the Glucose-Stimulated Increase of Intramuscular Glucose-6-Phosphate Concentration in Humans
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2153 - 2160.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. A. St. Amand, L. L. Spriet, N. L. Jones, and G. J. F. Heigenhauser
Pyruvate overrides inhibition of PDH during exercise after a low-carbohydrate diet
Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E275 - E283.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. K. Kim, O. Gavrilova, Y. Chen, M. L. Reitman, and G. I. Shulman
Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice
J. Biol. Chem., March 17, 2000; 275(12): 8456 - 8460.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Fery, L. Plat, and E. O. Balasse
Effect of fasting on the intracellular metabolic partition of intravenously infused glucose in humans
Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E815 - E823.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. S. Sidossis, B. Mittendorfer, D. Chinkes, E. Walser, and R. R. Wolfe
Effect of hyperglycemia-hyperinsulinemia on whole body and regional fatty acid metabolism
Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E427 - E434.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Fery, L. Plat, M. Baleriaux, and E. O. Balasse
Inhibition of Lipolysis Stimulates Whole Body Glucose Production and Disposal in Normal Postabsorptive Subjects
J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 825 - 830.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 European Society of Endocrinology.